Sfoglia per Rivista DIABETES
Raised C-reactive protein in recent onset type 1 diabetes
2005-01-01 Picardi, A; Valorani, Mg; Cio-Fini, O; Manfrini, S; D'Avola, D; Valente, L; Cappa, M; Pozzilli, P; Grp, I
Raised levels of reg1-alpha in sera of subjects with type I diabetes: Evidence for beta cell regeneration
2007-01-01 Guglielmi, C; Battistoni, F; Valente, L; Astorri, E; Valorani, Mg; Pozzilli, P; Imdiab, G.
Recent data from the DIA-AID 1, a Global Phase III clinical study in newly diagnosed Type 1 diabetes patients
2012-01-01 Dagan, S; Ziegler, A; Pozzilli, P; Linn, T; Schernthaner, G; Bonnici, F; Elias, D; Ebren, R; Cohen, I; Raz, I; 901 Study, Group
Reduction of body weight through diet and the use of glucose rapidspray
2007-01-01 Khazrai, Ym; Altomare, M; Visalli, N; Cipolloni, L; Maurizi, Am; Pozzilli, P
Regulation of TRAIL-mediated human beta-cells destruction by FADD and NF-kappa B
2003-01-01 Ou, Dw; Wang, Xj; Metzger, D; Jobin, C; Chantler, J; James, R; Pozzilli, P; Tingle, A
Residual beta cell function as assessed by baseline C-peptide is an independent factor from glucose levels at the time of blood sampling
2002-01-01 Visalli, N; Suraci, C; Leotta, S; Pozzilli, P; Imdiab, G
Risk Factors for Fragility Fractures in Type 1 Diabetes
2016-01-01 Leanza, G; Pitocco, D; Suraci, C; Altomare, M; Palermo, A; Pedone, C; Leotta, S; Zanoboni, L; Paratore, G; Pozzilli, P; Schwartz, Av; Napoli, N
SIB-PAIR ANALYSIS OF ADENOSINE-DEAMINASE LOCUS IN NIDDM
1992-01-01 Baroni, Mg; Alcolado, Jc; Needham, Ewa; Pozzilli, P; Stocks, J; Galton, Dj
Similar Frequencies of HLA Risk Genotypes in Type 1 Diabetes over the past Six Decades in a Caucasian Population
2009-01-01 Spoletini, M; Zampetti, S; Petrone, A; Capizzi, M; Venditti, C; Pozzilli, P; Buzzetti, R; Imdiab, G
Study of CTLA-4 gene expression in patients with IDDM.
1997-01-01 Cavallo, Mg; Leytze, G; Buzzetti, R; Nistico, L; Linsley, P; Pozzilli, P
T cell lines to bovine beta-casein in Type 1 diabetes
2000-01-01 Monetini, L; Cavallo, Mg; Stefanini, L; Coppolino, G; Walk, T; Jung, G; Pozzilli, P
The Efficacy of Continuous Glucose Monitoring to Improve BMI and Glycaemic Control in Prediabetes: The OBIG Trial
2015-01-01 Defeudis, G; Di Emidio, C; Strollo, R; Angeletti, S
The natural history of C-peptide secretion in the first year of type 1 diabetes
2003-01-01 Visalli, N; Crino, A; Spera, S; Costanza, F; Fioriti, E; Corbi, S; Beretta, G; Pozzilli, P
TRAIL death signal transduction pathway mediated human beta-cell destruction
2002-01-01 Ou, Dw; Wang, Xj; Metzger, D; Huang, Jq; Pozzilli, P; Tingle, A.
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia
2008-01-01 Khazrai, M; Cacciapaglia, F; Picardi, A; Anguissola, Gb; Guglielmi, C; Manfrini, S; Pozzilli, P
Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study)
2003-01-01 Prisco, F; Iafusco, D; Lorini, R; Minicucci, L; Martinucci, M; Toni, S; Cerrutti, F; Rabbone, I; Crino, A; Pozzilli, P
Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes
1997-01-01 Hawa, M; Rowe, R; Lan, Ms; Notkins, Al; Pozzilli, P; Christie, Mr; Leslie, Rdg
Vitamin D supplementation in patients with recent onset type I diabetes: IMDIAB XI trial
2003-01-01 Pozzilli, P; Crino, A; Costantino, F; Manfrini, S; Spera, S; Suraci, C; Pitocco, D; Patera, P; Matteoli, M; Schiaffini, R; Ghirlanda, G; Leotta, S; Visalli, N
WNT Pathway and Bone Fragility in Postmenopausal Women with Type 2 Diabetes
2019-01-01 Piccoli, A; Cannata, F; Russo, F; Greto, Vl; Isgro, C; Leanza, G; Strollo, R; Massaroni, C; Pedone, C; Silvestri, S; Vadala, G; Denaro, V; Bisogno, T; Papalia, R; Pozzilli, P; Maccarrone, M; Napoli, N
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Raised C-reactive protein in recent onset type 1 diabetes | 1-gen-2005 | Picardi, A; Valorani, Mg; Cio-Fini, O; Manfrini, S; D'Avola, D; Valente, L; Cappa, M; Pozzilli, P; Grp, I | |
| Raised levels of reg1-alpha in sera of subjects with type I diabetes: Evidence for beta cell regeneration | 1-gen-2007 | Guglielmi, C; Battistoni, F; Valente, L; Astorri, E; Valorani, Mg; Pozzilli, P; Imdiab, G. | |
| Recent data from the DIA-AID 1, a Global Phase III clinical study in newly diagnosed Type 1 diabetes patients | 1-gen-2012 | Dagan, S; Ziegler, A; Pozzilli, P; Linn, T; Schernthaner, G; Bonnici, F; Elias, D; Ebren, R; Cohen, I; Raz, I; 901 Study, Group | |
| Reduction of body weight through diet and the use of glucose rapidspray | 1-gen-2007 | Khazrai, Ym; Altomare, M; Visalli, N; Cipolloni, L; Maurizi, Am; Pozzilli, P | |
| Regulation of TRAIL-mediated human beta-cells destruction by FADD and NF-kappa B | 1-gen-2003 | Ou, Dw; Wang, Xj; Metzger, D; Jobin, C; Chantler, J; James, R; Pozzilli, P; Tingle, A | |
| Residual beta cell function as assessed by baseline C-peptide is an independent factor from glucose levels at the time of blood sampling | 1-gen-2002 | Visalli, N; Suraci, C; Leotta, S; Pozzilli, P; Imdiab, G | |
| Risk Factors for Fragility Fractures in Type 1 Diabetes | 1-gen-2016 | Leanza, G; Pitocco, D; Suraci, C; Altomare, M; Palermo, A; Pedone, C; Leotta, S; Zanoboni, L; Paratore, G; Pozzilli, P; Schwartz, Av; Napoli, N | |
| SIB-PAIR ANALYSIS OF ADENOSINE-DEAMINASE LOCUS IN NIDDM | 1-gen-1992 | Baroni, Mg; Alcolado, Jc; Needham, Ewa; Pozzilli, P; Stocks, J; Galton, Dj | |
| Similar Frequencies of HLA Risk Genotypes in Type 1 Diabetes over the past Six Decades in a Caucasian Population | 1-gen-2009 | Spoletini, M; Zampetti, S; Petrone, A; Capizzi, M; Venditti, C; Pozzilli, P; Buzzetti, R; Imdiab, G | |
| Study of CTLA-4 gene expression in patients with IDDM. | 1-gen-1997 | Cavallo, Mg; Leytze, G; Buzzetti, R; Nistico, L; Linsley, P; Pozzilli, P | |
| T cell lines to bovine beta-casein in Type 1 diabetes | 1-gen-2000 | Monetini, L; Cavallo, Mg; Stefanini, L; Coppolino, G; Walk, T; Jung, G; Pozzilli, P | |
| The Efficacy of Continuous Glucose Monitoring to Improve BMI and Glycaemic Control in Prediabetes: The OBIG Trial | 1-gen-2015 | Defeudis, G; Di Emidio, C; Strollo, R; Angeletti, S | |
| The natural history of C-peptide secretion in the first year of type 1 diabetes | 1-gen-2003 | Visalli, N; Crino, A; Spera, S; Costanza, F; Fioriti, E; Corbi, S; Beretta, G; Pozzilli, P | |
| TRAIL death signal transduction pathway mediated human beta-cell destruction | 1-gen-2002 | Ou, Dw; Wang, Xj; Metzger, D; Huang, Jq; Pozzilli, P; Tingle, A. | |
| Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia | 1-gen-2008 | Khazrai, M; Cacciapaglia, F; Picardi, A; Anguissola, Gb; Guglielmi, C; Manfrini, S; Pozzilli, P | |
| Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study) | 1-gen-2003 | Prisco, F; Iafusco, D; Lorini, R; Minicucci, L; Martinucci, M; Toni, S; Cerrutti, F; Rabbone, I; Crino, A; Pozzilli, P | |
| Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes | 1-gen-1997 | Hawa, M; Rowe, R; Lan, Ms; Notkins, Al; Pozzilli, P; Christie, Mr; Leslie, Rdg | |
| Vitamin D supplementation in patients with recent onset type I diabetes: IMDIAB XI trial | 1-gen-2003 | Pozzilli, P; Crino, A; Costantino, F; Manfrini, S; Spera, S; Suraci, C; Pitocco, D; Patera, P; Matteoli, M; Schiaffini, R; Ghirlanda, G; Leotta, S; Visalli, N | |
| WNT Pathway and Bone Fragility in Postmenopausal Women with Type 2 Diabetes | 1-gen-2019 | Piccoli, A; Cannata, F; Russo, F; Greto, Vl; Isgro, C; Leanza, G; Strollo, R; Massaroni, C; Pedone, C; Silvestri, S; Vadala, G; Denaro, V; Bisogno, T; Papalia, R; Pozzilli, P; Maccarrone, M; Napoli, N |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile